The Institutional Biosafety Committee (IBC) is a standing committee and is responsible for reviewing all University research and teaching activities conducted by faculty, staff, students and/or visiting scientists on University property that involve the use of biological agents. Biological agents are defined as microorganisms, Recombinant or Synthetic Nucleic Acid Molecules experiments as defined by NIH Guidelines, materials derived from human and non-human primates, or biological toxins.
The mission of the IBC is to ensure that all activities involving biological agents and the facilities used to conduct such work are in compliance with all external regulations, and applicable University policies.
The committee will function to ensure that investigators handle biological agents in a safe and responsible manner, and meet criteria as described by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules; the CDC/NIH publication Biosafety in the Microbiological and Biomedical Laboratories; applicable regulations defined by the Virginia Department of Environmental Quality; the OSHA Bloodborne Pathogens Standard; HHS and USDA final rules for the possession, use, and transfer of select agents and toxins; and other applicable requirements. Foremost, the IBC's objective shall be to ensure that such activities meet the standards of good biological safety practice emphasizing protection of personnel, the public and the environment.
The IBC shall assist principal investigators and protocol directors in meeting their responsibilities; impose requirements; and review and approve policies, proposals, procedures, programs, and facilities pursuant to the safe and legally compliant use of biological agents.
If you would like to attend a meeting, please contact Paul Skoglund at ps5d@virginia.edu or 434-243-0726, by the date the Registration Documents are due.
| Date of IBC Meeting | Date Registration (IAR) Documents are due |
|---|---|
| January 3rd, 2023 | December 19th, 2022 |
| February 7th, 2023 | January 25th, 2023 |
| March 7th, 2023 | February 22nd, 2023 |
| April 4th, 2023 | March 22nd, 2023 |
| May 2nd, 2023 | April 19th, 2023 |
| June 6th, 2023 | May 24th, 2023 |
| July 6th, 2023 (Thursday) | June 21st, 2023 |
| August 1st, 2023 | July 19th, 2023 |
| September 5th, 2023 | August 23rd, 2023 |
| October 3rd, 2023 | September 20th, 2023 |
| November 9th, 2023 (Thursday) | October 25th, 2023 |
| December 5th, 2023 | November 15th, 2023 |
| January 4rd, 2024 (Thursday) | December 18th, 2023 |
Prof. Barbara J. Mann
IBC Chair
Associate Professor
Department of Medicine, Infectious Diseases
434-924-9666
Stacy Agar
IBC Member
Community Member
512-583-2485
Kumari Andarawewa
IBC Member
Associate Director of the Center for Comparative Medicine
434-924-2090
Jennifer Kershner
UVA Biosafety Officer
Alternate Responsible Official (Select Agents)
434.982.4911
Marie Burdick
IBC Member
Principal Scientist
Department of Medicine, Pulmonary and Critical Care
434-243-7363
Sam Driver
IBC Member
Community Member
434-973-4333
Glynis L. Kolling
IBC Member
Assistant Professor of Medicine
Department of Biomedical Engineering
434-924-5630
Tom Leonard
IBC Member
Responsible Official (Select Agents)
EHS Director
434.982.4911
Prof. Aaron L. Mills
IBC Member
Professor
Department of Environmental Sciences
434-924-0564
Prof. Ira Schulman
IBC Member
Associate Professor
Department of Pharmacology
434-924-5682
Prof. Scott Vande Pol
IBC Member
Associate Professor
Department of Pathology
434-924-1603
Paul Skoglund
IBC Coordinator
434-243-0726
